JP6002816B2 - Oil / vesicle / water emulsion composition and cosmetics containing the same - Google Patents
Oil / vesicle / water emulsion composition and cosmetics containing the same Download PDFInfo
- Publication number
- JP6002816B2 JP6002816B2 JP2015117262A JP2015117262A JP6002816B2 JP 6002816 B2 JP6002816 B2 JP 6002816B2 JP 2015117262 A JP2015117262 A JP 2015117262A JP 2015117262 A JP2015117262 A JP 2015117262A JP 6002816 B2 JP6002816 B2 JP 6002816B2
- Authority
- JP
- Japan
- Prior art keywords
- vesicle
- oil
- component
- glycol
- emulsion composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 85
- 239000000839 emulsion Substances 0.000 title claims description 54
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims description 26
- 239000002537 cosmetic Substances 0.000 title claims description 16
- -1 polyglycerin Chemical compound 0.000 claims description 52
- 239000002245 particle Substances 0.000 claims description 32
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 21
- 239000000126 substance Substances 0.000 claims description 18
- 230000007704 transition Effects 0.000 claims description 16
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 claims description 14
- 150000005846 sugar alcohols Polymers 0.000 claims description 14
- 239000002202 Polyethylene glycol Substances 0.000 claims description 11
- 229920001223 polyethylene glycol Polymers 0.000 claims description 11
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 10
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims description 10
- 238000002844 melting Methods 0.000 claims description 9
- 230000008018 melting Effects 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 6
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 claims description 6
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 claims description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 claims description 4
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 claims description 4
- ZIIVEKCKOPDBLT-UHFFFAOYSA-N 2-octyldodecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCC(COC(=O)C(C)O)CCCCCCCC ZIIVEKCKOPDBLT-UHFFFAOYSA-N 0.000 claims description 4
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 claims description 4
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 229940077397 octyldodecyl lactate Drugs 0.000 claims description 4
- 150000003905 phosphatidylinositols Chemical class 0.000 claims description 4
- 229940116422 propylene glycol dicaprate Drugs 0.000 claims description 4
- 229940083466 soybean lecithin Drugs 0.000 claims description 4
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 claims description 3
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 claims description 3
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 claims description 3
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims description 3
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 claims description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 3
- 229940051250 hexylene glycol Drugs 0.000 claims description 3
- 229940100554 isononyl isononanoate Drugs 0.000 claims description 3
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 3
- 150000008104 phosphatidylethanolamines Chemical class 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- 229930195734 saturated hydrocarbon Natural products 0.000 claims description 3
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 claims description 3
- 229930195735 unsaturated hydrocarbon Natural products 0.000 claims description 3
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 claims description 2
- HFWHTGSLDKKCMD-UHFFFAOYSA-N 2,2-bis(octanoyloxymethyl)butyl octanoate Chemical compound CCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCC)COC(=O)CCCCCCC HFWHTGSLDKKCMD-UHFFFAOYSA-N 0.000 claims description 2
- JAUFWPNLLLUYNV-UHFFFAOYSA-N 3-(16-methylheptadecoxy)propane-1,2-diol Chemical compound CC(C)CCCCCCCCCCCCCCCOCC(O)CO JAUFWPNLLLUYNV-UHFFFAOYSA-N 0.000 claims description 2
- 229940105990 diglycerin Drugs 0.000 claims description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 229920001451 polypropylene glycol Polymers 0.000 claims description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 1
- 239000003921 oil Substances 0.000 description 65
- 239000012071 phase Substances 0.000 description 24
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 20
- 230000005068 transpiration Effects 0.000 description 14
- 150000003904 phospholipids Chemical class 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 230000001629 suppression Effects 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 239000004359 castor oil Substances 0.000 description 7
- 235000019438 castor oil Nutrition 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 7
- 239000000787 lecithin Substances 0.000 description 7
- 235000010445 lecithin Nutrition 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 229940067606 lecithin Drugs 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 6
- 238000004945 emulsification Methods 0.000 description 5
- 238000001000 micrograph Methods 0.000 description 5
- 230000003020 moisturizing effect Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 239000002270 dispersing agent Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000001804 emulsifying effect Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 150000002327 glycerophospholipids Chemical class 0.000 description 3
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 3
- 229940100608 glycol distearate Drugs 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- 150000002894 organic compounds Chemical class 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- 229920003169 water-soluble polymer Polymers 0.000 description 3
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- AVBJHQDHVYGQLS-AWEZNQCLSA-N (2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-AWEZNQCLSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- BBMCTIGTTCKYKF-UHFFFAOYSA-N 1-heptanol Chemical compound CCCCCCCO BBMCTIGTTCKYKF-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- ZPDQFUYPBVXUKS-YADHBBJMSA-N 1-stearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(O)(=O)OC[C@H](N)C(O)=O ZPDQFUYPBVXUKS-YADHBBJMSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 2
- IZHVBANLECCAGF-UHFFFAOYSA-N 2-hydroxy-3-(octadecanoyloxy)propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC IZHVBANLECCAGF-UHFFFAOYSA-N 0.000 description 2
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 2
- BJRXGOFKVBOFCO-UHFFFAOYSA-N 2-hydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(C)O BJRXGOFKVBOFCO-UHFFFAOYSA-N 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- 229930183167 cerebroside Natural products 0.000 description 2
- RIZIAUKTHDLMQX-UHFFFAOYSA-N cerebroside D Natural products CCCCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=C(C)CCCCCCCCC)COC1OC(CO)C(O)C(O)C1O RIZIAUKTHDLMQX-UHFFFAOYSA-N 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 150000005690 diesters Chemical class 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 239000004973 liquid crystal related substance Substances 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 2
- 229940117969 neopentyl glycol Drugs 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- 229940049964 oleate Drugs 0.000 description 2
- 230000010287 polarization Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 2
- 229940117972 triolein Drugs 0.000 description 2
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 1
- OSELKOCHBMDKEJ-UHFFFAOYSA-N (10R)-3c-Hydroxy-10r.13c-dimethyl-17c-((R)-1-methyl-4-isopropyl-hexen-(4c)-yl)-(8cH.9tH.14tH)-Delta5-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(=CC)C(C)C)C1(C)CC2 OSELKOCHBMDKEJ-UHFFFAOYSA-N 0.000 description 1
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
- QQVDJLLNRSOCEL-UHFFFAOYSA-N (2-aminoethyl)phosphonic acid Chemical compound [NH3+]CCP(O)([O-])=O QQVDJLLNRSOCEL-UHFFFAOYSA-N 0.000 description 1
- FROLUYNBHPUZQU-IIZJPUEISA-N (2R,3R,4S,5R)-2-(hydroxymethyl)-6-[3-[3-[(3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropoxy]propoxy]oxane-3,4,5-triol Chemical compound OC[C@H]1OC(OCCCOCCCOC2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O FROLUYNBHPUZQU-IIZJPUEISA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 1
- QHZLMUACJMDIAE-UHFFFAOYSA-N 1-monopalmitoylglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)CO QHZLMUACJMDIAE-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- WRGQSWVCFNIUNZ-GDCKJWNLSA-N 1-oleoyl-sn-glycerol 3-phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)COP(O)(O)=O WRGQSWVCFNIUNZ-GDCKJWNLSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
- FZGBADVTTLOFPU-UHFFFAOYSA-N 2-(2-dodecanoyloxyethoxy)ethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOCCOC(=O)CCCCCCCCCCC FZGBADVTTLOFPU-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- XNKMPLWXFAJIRB-UHFFFAOYSA-N 2-[2-(16-methylheptadecanoyloxy)ethoxy]ethyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCOCCOC(=O)CCCCCCCCCCCCCCC(C)C XNKMPLWXFAJIRB-UHFFFAOYSA-N 0.000 description 1
- YBRJTUFWBLSLHY-UHFFFAOYSA-N 2-[2-(2-octadecanoyloxyethoxy)ethoxy]ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCOCCOC(=O)CCCCCCCCCCCCCCCCC YBRJTUFWBLSLHY-UHFFFAOYSA-N 0.000 description 1
- HJRDNARELSKHEF-CLFAGFIQSA-N 2-[2-[(z)-octadec-9-enoyl]oxyethoxy]ethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCOCCOC(=O)CCCCCCC\C=C/CCCCCCCC HJRDNARELSKHEF-CLFAGFIQSA-N 0.000 description 1
- ALVGIJJKUWXGCF-UHFFFAOYSA-N 2-[2-[2-(16-methylheptadecanoyloxy)ethoxy]ethoxy]ethyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCOCCOCCOC(=O)CCCCCCCCCCCCCCC(C)C ALVGIJJKUWXGCF-UHFFFAOYSA-N 0.000 description 1
- IFWVXSTYAPCLGQ-CLFAGFIQSA-N 2-[2-[2-[(Z)-octadec-9-enoyl]oxyethoxy]ethoxy]ethyl (Z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCOCCOCCOC(=O)CCCCCCC\C=C/CCCCCCCC IFWVXSTYAPCLGQ-CLFAGFIQSA-N 0.000 description 1
- ZVUNTIMPQCQCAQ-UHFFFAOYSA-N 2-dodecanoyloxyethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCC ZVUNTIMPQCQCAQ-UHFFFAOYSA-N 0.000 description 1
- WITKSCOBOCOGSC-UHFFFAOYSA-N 2-dodecanoyloxypropyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCCCC WITKSCOBOCOGSC-UHFFFAOYSA-N 0.000 description 1
- HZDXMOKVXIMEOG-UHFFFAOYSA-N 2-hexyldecyl 3-[methyl(tetradecanoyl)amino]propanoate Chemical compound CCCCCCCCCCCCCC(=O)N(C)CCC(=O)OCC(CCCCCC)CCCCCCCC HZDXMOKVXIMEOG-UHFFFAOYSA-N 0.000 description 1
- ZVTDEEBSWIQAFJ-KHPPLWFESA-N 2-hydroxypropyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C)O ZVTDEEBSWIQAFJ-KHPPLWFESA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
- BUUSNVSJZVGMFY-UHFFFAOYSA-N 4-ethylheptane-3,3-diol Chemical compound CCCC(CC)C(O)(O)CC BUUSNVSJZVGMFY-UHFFFAOYSA-N 0.000 description 1
- MQWCXKGKQLNYQG-UHFFFAOYSA-N 4-methylcyclohexan-1-ol Chemical compound CC1CCC(O)CC1 MQWCXKGKQLNYQG-UHFFFAOYSA-N 0.000 description 1
- BIBSVSRJRVSBNF-MFERNQICSA-N 5-o-octadecanoyl 1-o-(9-octylicosan-9-yl) (2s)-2-aminopentanedioate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(=O)CC[C@H](N)C(=O)OC(CCCCCCCC)(CCCCCCCC)CCCCCCCCCCC BIBSVSRJRVSBNF-MFERNQICSA-N 0.000 description 1
- CQSRUKJFZKVYCY-UHFFFAOYSA-N 5alpha-isofucostan-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(=CC)C(C)C)C1(C)CC2 CQSRUKJFZKVYCY-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 241000588986 Alcaligenes Species 0.000 description 1
- OILXMJHPFNGGTO-NRHJOKMGSA-N Brassicasterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@](C)([C@H]([C@@H](/C=C/[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 OILXMJHPFNGGTO-NRHJOKMGSA-N 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical compound CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- GBBBJSKVBYJMBG-QTWVXCTBSA-N Fucosterol Natural products CC=C(CC[C@@H](C)[C@@H]1CC[C@@H]2[C@H]3C=C[C@@H]4C[C@H](O)CC[C@@]4(C)[C@@H]3CC[C@@]12C)C(C)C GBBBJSKVBYJMBG-QTWVXCTBSA-N 0.000 description 1
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- OSELKOCHBMDKEJ-VRUYXKNBSA-N Isofucosterol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@@H]2[C@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C)C(C)C OSELKOCHBMDKEJ-VRUYXKNBSA-N 0.000 description 1
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ZQQLMECVOXKFJK-NXCSZAMKSA-N N-octadecanoylsphingosine 1-phosphate Chemical class CCCCCCCCCCCCCCCCCC(=O)N[C@@H](COP(O)(O)=O)[C@H](O)\C=C\CCCCCCCCCCCCC ZQQLMECVOXKFJK-NXCSZAMKSA-N 0.000 description 1
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-ZRUUVFCLSA-N UNPD197407 Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)C=C[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZRUUVFCLSA-N 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
- AQKOHYMKBUOXEB-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-(16-methylheptadecanoyloxy)oxolan-2-yl]-2-(16-methylheptadecanoyloxy)ethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCC(C)C)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCC(C)C AQKOHYMKBUOXEB-RYNSOKOISA-N 0.000 description 1
- CWRILEGKIAOYKP-SSDOTTSWSA-M [(2r)-3-acetyloxy-2-hydroxypropyl] 2-aminoethyl phosphate Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCCN CWRILEGKIAOYKP-SSDOTTSWSA-M 0.000 description 1
- CMPDPBDUZTUXAD-UHFFFAOYSA-N [3-hydroxy-2-(16-methylheptadecanoyloxy)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC(C)C CMPDPBDUZTUXAD-UHFFFAOYSA-N 0.000 description 1
- ABKPAQVSXGDAOP-UHFFFAOYSA-N [5-(2,2-dimethylpropanoyloxy)-3-methylpentyl] 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OCCC(C)CCOC(=O)C(C)(C)C ABKPAQVSXGDAOP-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- QBEUXDWEKIOSIL-UHFFFAOYSA-N benzyl 5-amino-1h-pyrazole-4-carboxylate Chemical compound N1N=CC(C(=O)OCC=2C=CC=CC=2)=C1N QBEUXDWEKIOSIL-UHFFFAOYSA-N 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 239000003876 biosurfactant Substances 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- WLRZTBZLAQJGJP-OKTFGQEQSA-N bis(2-octyldodecyl) (2s)-2-(dodecanoylamino)pentanedioate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)[C@@H](NC(=O)CCCCCCCCCCC)CCC(=O)OCC(CCCCCCCC)CCCCCCCCCC WLRZTBZLAQJGJP-OKTFGQEQSA-N 0.000 description 1
- OILXMJHPFNGGTO-ZAUYPBDWSA-N brassicasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZAUYPBDWSA-N 0.000 description 1
- 235000004420 brassicasterol Nutrition 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- YKDMBTQVKVEMSA-UHFFFAOYSA-N diethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCOC(=O)CCCCCCCCCCCCCCCCC YKDMBTQVKVEMSA-UHFFFAOYSA-N 0.000 description 1
- 229940111071 diethylene glycol distearate Drugs 0.000 description 1
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
- FRKBLBQTSTUKOV-UHFFFAOYSA-N diphosphatidyl glycerol Natural products OP(O)(=O)OCC(OP(O)(O)=O)COP(O)(O)=O FRKBLBQTSTUKOV-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 229940042400 direct acting antivirals phosphonic acid derivative Drugs 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- ZGSPNIOCEDOHGS-UHFFFAOYSA-L disodium [3-[2,3-di(octadeca-9,12-dienoyloxy)propoxy-oxidophosphoryl]oxy-2-hydroxypropyl] 2,3-di(octadeca-9,12-dienoyloxy)propyl phosphate Chemical compound [Na+].[Na+].CCCCCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COP([O-])(=O)OCC(O)COP([O-])(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC ZGSPNIOCEDOHGS-UHFFFAOYSA-L 0.000 description 1
- LLRANSBEYQZKFY-UHFFFAOYSA-N dodecanoic acid;propane-1,2-diol Chemical compound CC(O)CO.CCCCCCCCCCCC(O)=O LLRANSBEYQZKFY-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- WSTZPWUPYWHZRR-UHFFFAOYSA-N ethene;2-ethyl-2-(hydroxymethyl)propane-1,3-diol Chemical compound C=C.CCC(CO)(CO)CO WSTZPWUPYWHZRR-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 150000004665 fatty acids Chemical group 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- HJUFTIJOISQSKQ-UHFFFAOYSA-N fenoxycarb Chemical compound C1=CC(OCCNC(=O)OCC)=CC=C1OC1=CC=CC=C1 HJUFTIJOISQSKQ-UHFFFAOYSA-N 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- OSELKOCHBMDKEJ-JUGJNGJRSA-N fucosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC\C(=C/C)C(C)C)[C@@]1(C)CC2 OSELKOCHBMDKEJ-JUGJNGJRSA-N 0.000 description 1
- 125000002519 galactosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)* 0.000 description 1
- 150000002270 gangliosides Chemical class 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229940074045 glyceryl distearate Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229940096898 glyceryl palmitate Drugs 0.000 description 1
- 150000002339 glycosphingolipids Chemical class 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 229940116371 hexyldecyl myristoyl methylaminopropionate Drugs 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 229940035429 isobutyl alcohol Drugs 0.000 description 1
- 229940058690 lanosterol Drugs 0.000 description 1
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 description 1
- 229940033329 phytosphingosine Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical group OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Landscapes
- Colloid Chemistry (AREA)
- Cosmetics (AREA)
Description
本発明は、水分蒸散抑制効果に優れた油/ベシクル/水型乳化組成物、その製造法、及び当該乳化組成物を含有する使用感の良好な化粧料に関する。 The present invention relates to an oil / vesicle / water emulsion composition excellent in moisture transpiration suppression effect, a method for producing the same, and a cosmetic material having a good feeling of use, containing the emulsion composition.
疎水性及び親水性の両方の性質を有する両親媒性物質のうち、例えば、リン脂質のように二分子膜からなる球状の小胞体を形成するものがある。このような閉鎖小胞体はベシクル又はリポソームと呼ばれ、その閉鎖小胞体内部に水溶性成分を、或いは小胞体膜内に油性成分を安定に保持することができる。このため、例えば薬剤を保持させて生体内に投与した場合、代謝が抑制され薬効を長期間にわたって維持できる等の利点から、医薬品や化粧品分野等におけるマイクロカプセルとして用いられている。 Among the amphiphilic substances having both hydrophobic and hydrophilic properties, there are those that form a spherical vesicle composed of a bilayer, such as phospholipid. Such closed vesicles are called vesicles or liposomes, and can stably hold a water-soluble component within the closed vesicle or an oily component within the vesicle membrane. For this reason, for example, when a drug is retained and administered into a living body, it is used as a microcapsule in the fields of pharmaceuticals, cosmetics and the like because of its advantages such as suppression of metabolism and maintenance of drug efficacy over a long period of time.
また、化粧料分野では、優れた保湿感を付与し、かつ良好な使用感を得るために多量の油分を安定に配合した水中油型乳化系の化粧品が開発されてきた。このため、ベシクルの機能を有しながら、多量の油分を配合した組成物の開発が望まれていたが、油性成分は小胞体膜内にのみしか保持する事しかできないため、ベシクル構造を維持したまま、多量に油分を配合する事は困難であった。 In the cosmetic field, oil-in-water emulsified cosmetics have been developed in which a large amount of oil is stably blended in order to impart an excellent moisturizing feeling and a good feeling to use. For this reason, it was desired to develop a composition containing a large amount of oil while having the function of a vesicle, but since the oil component can only be held only in the endoplasmic reticulum membrane, the vesicle structure was maintained. It was difficult to add a large amount of oil.
近年、自己組織化能を有する両親媒性物質により形成される閉鎖小胞体を主成分とすることを特徴とする乳化分散剤が提案されている(特許文献1、2)。この発明によれば、両親媒性物質のナノ粒子をファンデルワールス力によって、油性基剤表面に付着させ、これにより、水相−乳化分散剤相−油相の三相構造を形成し、従来の界面活性剤と異なって相溶性による界面エネルギーの低下を起こさせることなく、熱衝突による合一が起こりにくくなり、乳化物の安定性に優れることが示されている。 In recent years, an emulsifying dispersant having a closed vesicle formed of an amphiphilic substance having a self-organizing ability as a main component has been proposed (Patent Documents 1 and 2). According to the present invention, nanoparticles of an amphiphilic substance are attached to the surface of an oily base by van der Waals force, thereby forming a three-phase structure of an aqueous phase, an emulsifying dispersant phase, and an oil phase. It has been shown that coalescence by thermal collision is less likely to occur without causing a decrease in interfacial energy due to compatibility, and the stability of the emulsion is excellent.
しかしながら、前記閉鎖小胞体を主成分とする乳化分散剤によれば、ベシクル構造を有したまま、ある程度の油分を配合する事は可能であるが、界面膜状に付着するベシクルはナノ粒子であることが必要であり、高圧乳化法等により単粒子化されたバイオポリマーの配合が必要であった。高圧乳化法を用いた場合、装置コストが高く、しかも生産性が低いという制限があるため、その使用範囲は限られていた。
従って、本発明の課題は、汎用な製造方法でも製造可能で、皮膚に有用な油分を多量に安定に配合する事ができ、水分蒸散抑制効果に優れ、さらに使用感の良好な水中油型乳化組成物を提供するにある。
However, according to the emulsifying dispersant having the closed vesicle as a main component, it is possible to add a certain amount of oil while maintaining the vesicle structure, but the vesicle attached to the interface film is a nanoparticle. In other words, it was necessary to blend a biopolymer that was made into single particles by a high-pressure emulsification method or the like. When the high-pressure emulsification method is used, the range of use is limited because there is a limitation that the apparatus cost is high and the productivity is low.
Therefore, the object of the present invention is an oil-in-water emulsification that can be produced by a general-purpose production method, can stably blend a large amount of oil useful for the skin, has an excellent effect of suppressing moisture transpiration, and has a good usability. To provide a composition.
そこで本発明者は、種々検討した結果、両親媒性物質に、一定のIOB値を有する油分、多価アルコール及び水を用い、両親媒性物質と特定の油分からなるベシクルを油水界面膜上で形成させることにより、油分が前記ベシクルにより被覆された油性粒子を形成させることができ、多量の油分を配合可能で、水分蒸散抑制効果に優れ、使用感の良好な乳化組成物が得られることを見出し、本発明を完成した。 Therefore, as a result of various studies, the present inventor has used an oil component having a certain IOB value, a polyhydric alcohol, and water as an amphiphilic substance, and a vesicle composed of the amphiphilic substance and a specific oil component on the oil-water interface film. By forming, oily particles whose oil content is coated with the vesicles can be formed, a large amount of oil content can be blended, and an emulsified composition with excellent moisture transpiration control effect and good usability can be obtained. The headline and the present invention were completed.
すなわち、本発明は、下記成分(A)〜(D)からなる油/ベシクル/水型乳化組成物を提供するものである。
(A)両親媒性物質
(B)IOB値が0.2〜0.54で、融点が30℃以下の油分からなる群より選択される1種又は2種以上
(C)多価アルコール
(D)水性成分
That is, the present invention provides an oil / vesicle / water emulsion composition comprising the following components (A) to (D).
(A) Amphiphile (B) One or more selected from the group consisting of oils having an IOB value of 0.2 to 0.54 and a melting point of 30 ° C. or less (C) Polyhydric alcohol (D Aqueous component
また、本発明は、(A)両親媒性物質と、(B)IOB値が0.2〜0.54で、融点が30℃以下の油分からなる群より選択される1種又は2種以上の一部とからなるベシクルにより、当該ベシクルに含まれない成分(B)の表面が被覆されてなることを特徴とするベシクル被覆油性粒子を提供するものである。 Moreover, this invention is 1 type (s) or 2 or more types selected from the group which consists of (A) amphiphile, (B) IOB value is 0.2-0.54, and melting | fusing point is 30 degrees C or less. The vesicle-coated oily particles are provided in which the surface of the component (B) not contained in the vesicle is coated with a vesicle composed of a part of the vesicle.
さらに本発明は、前記ベシクル被覆油性粒子又は油/ベシクル/水型乳化組成物を含有する化粧料を提供するものである。 Furthermore, the present invention provides a cosmetic containing the vesicle-coated oily particles or the oil / vesicle / water emulsion composition.
さらに、本発明は、
(1)下記成分(A)〜(C)を相転移温度以上に加熱し、均一に混合し、
(A)両親媒性物質
(B)IOB値が0.2〜0.54で、融点が30℃以下の油分からなる群より選択される1種又は2種以上
(C)多価アルコール
(2)水性成分を相転移温度以上に加熱し、
(3)前記(2)に、前記(1)を加えて均一に混合する
ことを特徴とする油/ベシクル/水型乳化組成物の製造方法を提供するものである。
Furthermore, the present invention provides
(1) The following components (A) to (C) are heated to the phase transition temperature or higher and mixed uniformly.
(A) Amphiphile (B) One or more selected from the group consisting of oils having an IOB value of 0.2 to 0.54 and a melting point of 30 ° C. or lower (C) Polyhydric alcohol (2 ) Heat the aqueous component above the phase transition temperature,
(3) The present invention provides a method for producing an oil / vesicle / water emulsion composition, wherein (1) is added to (2) and mixed uniformly.
本発明によれば、油分と水性成分との油水界面上で、(A)両親媒性物質と、界面近傍の(B)油分の一部からベシクルが形成され、そのベシクルによって残りの(B)油分の表面が覆われることでベシクル被覆油性粒子が形成される。このベシクル被覆油性粒子を分散相に含有する油/ベシクル/水型(O/V/W)乳化組成物は、べシクルの特性を生かしつつ、皮膚に有用な油分を多量に含むことができ、水分蒸散抑制効果に優れ、さらに使用感の良好な組成物を得ることができる。特に化粧料、医薬品等として有用である。 According to the present invention, a vesicle is formed from (A) an amphiphile and a part of (B) oil in the vicinity of the interface on the oil / water interface between the oil and the aqueous component, and the remaining (B) is formed by the vesicle. Vesicle-coated oily particles are formed by covering the surface of the oil. The oil / vesicle / water (O / V / W) emulsion composition containing the vesicle-coated oily particles in the dispersed phase can contain a large amount of oil useful for the skin while taking advantage of the characteristics of the vesicle, It is possible to obtain a composition having an excellent effect of suppressing moisture transpiration and a good feeling upon use. In particular, it is useful as cosmetics, pharmaceuticals and the like.
本発明におけるベシクル被覆油性粒子とは、油分と水性成分との油水界面上で、(A)両親媒性物質と、界面近傍の(B)油分の一部とからベシクルが形成され、そのベシクルによって残りの(B)油分の表面が覆われた油性粒子を意味する。
本発明における油/ベシクル/水型乳化組成物(以下、O/V/W乳化組成物)とは、水性成分が連続相であり、前記ベシクル被覆油性粒子が分散相となる乳化組成物を意味する。
The vesicle-coated oil-based particles in the present invention are formed on the oil / water interface between the oil and the aqueous component, and the vesicle is formed from (A) an amphiphile and (B) a part of the oil in the vicinity of the interface. The remaining (B) means oily particles whose surface is covered with oil.
The oil / vesicle / water emulsion composition (hereinafter referred to as O / V / W emulsion composition) in the present invention means an emulsion composition in which an aqueous component is a continuous phase and the vesicle-coated oily particles are a dispersed phase. To do.
本発明におけるIOB値とは、Inorganic/Organic Balance(無機性/有機性比)の略であって、化合物の有機値に対する化合物の無機値の比に対応する値であり、有機化合物の極性の度合いを示す指標である。具体的には、IOB値=無機性値/有機性値として表される。 The IOB value in the present invention is an abbreviation of Inorganic / Organic Balance (inorganic / organic ratio), and corresponds to the ratio of the inorganic value of the compound to the organic value of the compound, and the degree of polarity of the organic compound It is an index showing. Specifically, it is expressed as IOB value = inorganic value / organic value.
ここで、「無機性値」、「有機性値」のそれぞれについては、例えば、分子中の炭素原子1個について「有機性値」が20、同水酸基1個について「無機性値」が100といったように、各種原子又は官能基に応じた「無機性値」、「有機性値」が設定されており、有機化合物中の全ての原子及び官能基の「無機性値」、「有機性値」を積算することによって、当該有機化合物のIOB値が算出される(例えば、甲田善生 著、「有機概念図―基礎と応用―」11頁〜17頁、三共出版 1984年発行 参照)。 Here, for each of the “inorganic value” and “organic value”, for example, “organic value” is 20 for one carbon atom in the molecule, and “inorganic value” is 100 for one hydroxyl group. As described above, “inorganic value” and “organic value” corresponding to various atoms or functional groups are set, and “inorganic value” and “organic value” of all atoms and functional groups in the organic compound. Is integrated to calculate the IOB value of the organic compound (see, for example, Yoshio Koda, “Organic Conceptual Diagram—Basics and Applications”, pages 11-17, published by Sankyo Publishing, 1984).
本発明に用いられる(A)の両親媒性物質は、親水性と親脂性との両方を有する物質を意味し、そのような性質を有するリン脂質、グリセロ糖脂質、スフィンゴ糖脂質、ステロール、ポリマー、界面活性剤等が挙げられるが、ベシクルを形成する事ができる両親媒性物質であれば特に制限なく用いる事ができる。 The amphiphilic substance (A) used in the present invention means a substance having both hydrophilicity and lipophilicity, and phospholipid, glyceroglycolipid, sphingoglycolipid, sterol, polymer having such properties Surfactant and the like can be mentioned, but any amphiphilic substance capable of forming a vesicle can be used without particular limitation.
本発明に用いるリン脂質としては、グリセロリン脂質、スフィンゴリン脂質などが挙げられる。
グリセロリン脂質は、グリセロリン酸骨格を有する物質で、親油基として脂肪酸エステル、長鎖アルキルエーテル、ビニルエーテルなどを有している。具体的には、ホスファチジルコリン、ホスファチジルエタノールアミン、ホスファチジルセリン、ホスファジイルイノシトール、ホスファチジルイノシトールポリリン酸、ホスファチジルグリセロール、ジホスファチジルグリセロール(カルジオリピン)、ホスファチジン酸、リゾホスファチジルコリン、リゾホスファチジルエタノールアミン、リゾホスファチジルセリン、リゾホスファチジルイノシトール、リゾホスファチジルグリセロール、リゾホスファチジン酸などが挙げられる。
スフィンゴリン脂質は、スフィンゴシン、フィトスフィンゴシンなどの長鎖塩基又は長鎖脂肪酸と、リン酸又はホスホン酸を有しており、セラミド1−リン酸誘導体(スフィンゴミエリンなど)、セラミド1−ホスホン酸誘導体(セラミドアミノエチルホスホン酸など)が挙げられる。
Examples of the phospholipid used in the present invention include glycerophospholipid and sphingophospholipid.
Glycerophospholipid is a substance having a glycerophosphoric acid skeleton, and has a fatty acid ester, a long-chain alkyl ether, a vinyl ether or the like as a lipophilic group. Specifically, phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphadiylinositol, phosphatidylinositol polyphosphate, phosphatidylglycerol, diphosphatidylglycerol (cardiolipin), phosphatidic acid, lysophosphatidylcholine, lysophosphatidylethanolamine, lysophosphatidylserine, lysophosphatidylserine, Examples include phosphatidylinositol, lysophosphatidylglycerol, and lysophosphatidic acid.
Sphingophospholipids have long-chain bases or long-chain fatty acids such as sphingosine and phytosphingosine, and phosphoric acid or phosphonic acid. Ceramide 1-phosphate derivatives (such as sphingomyelin), ceramide 1-phosphonic acid derivatives ( Ceramide aminoethylphosphonic acid and the like).
グリセロ糖脂質としては、例えばスルホキシリボシルグリセリド、ジグリコシルジグリセリド、ジガラクトシルジグリセリド、ガラクトシルジグリセリド、グリコシルジグリセリド等が挙げられる。 Examples of the glyceroglycolipid include sulfoxyribosyl glyceride, diglycosyl diglyceride, digalactosyl diglyceride, galactosyl diglyceride, glycosyl diglyceride and the like.
スフィンゴ糖脂質としては、例えばガラクトシルセレブロシド、ラクトシルセレブロシド、ガングリオシド等が挙げられる。 Examples of the glycosphingolipid include galactosyl cerebroside, lactosyl cerebroside, ganglioside and the like.
ステロールとしては、例えばコレステロール、ジヒドロコレステロール、ラノステロール、β−シトステロール、カンペステロール、スチグマステロール、ブラシカステロール、エルゴカステロール、フコステロール、3β−[N−(N',N'−ジメチルアミノエチル)カルバモイル]コレステロール等が挙げられる。 Examples of sterols include cholesterol, dihydrocholesterol, lanosterol, β-sitosterol, campesterol, stigmasterol, brassicasterol, ergocasterol, fucosterol, and 3β- [N- (N ′, N′-dimethylaminoethyl) carbamoyl. ] Cholesterol and the like.
ポリマーとしては、N−[1−(2,3−ジオレオイルプロピル)]−N,N,N−トリメチル塩化アンモニウム、N−[1−(2,3−ジオレオイルプロピル)]−N,N−ジメチルアミン、N−[1−(2,3−ジオレイルオキシプロピル)]−N,N,N−トリメチル塩化アンモニウム、2,3−ジオレイルオキシ−N−[2−(スペルミンカルボキシアミド)エチル]−N,N−ジメチル−1−プロパナミニウムトリフルオロ酢酸、N−[1−(2,3−ジテトラデシルオキシプロピル)]−N,N−ジメチル−N−ヒドロキシエチル臭化アンモニウム、N−[1−(2,3−ジオレイルオキシプロピル)]−N,N−ジメチル−N−ヒドロキシエチル臭化アンモニウム等が挙げられる。 As the polymer, N- [1- (2,3-dioleoylpropyl)]-N, N, N-trimethylammonium chloride, N- [1- (2,3-dioleoylpropyl)]-N, N-dimethylamine, N- [1- (2,3-dioleyloxypropyl)]-N, N, N-trimethylammonium chloride, 2,3-dioleyloxy-N- [2- (sperminecarboxamide) Ethyl] -N, N-dimethyl-1-propanaminium trifluoroacetic acid, N- [1- (2,3-ditetradecyloxypropyl)]-N, N-dimethyl-N-hydroxyethylammonium bromide, N- [1- (2,3-dioleyloxypropyl)]-N, N-dimethyl-N-hydroxyethyl ammonium bromide and the like can be mentioned.
界面活性剤としては、例えばソルビタン脂肪酸エステル(ソルビタンモノラウレート、ソルビタンモノオレエート)、ポリオキシエチレン脂肪酸エステル(モノオレイン酸ポリオキシエチレンソルビタン)、ポリオキシエチレン誘導体(ポリオキシエチレン硬化ヒマシ油)、グリセリン脂肪酸エステル、バイオサーファクタント(Alcaligenes Polysacchaides:アルカシーラン、伯東社製;マンノシルソルビトールリピッド:サーフメロー、東洋紡績社製)等の非イオン界面活性剤が挙げられる。 Examples of the surfactant include sorbitan fatty acid ester (sorbitan monolaurate, sorbitan monooleate), polyoxyethylene fatty acid ester (polyoxyethylene sorbitan monooleate), polyoxyethylene derivative (polyoxyethylene hydrogenated castor oil), Nonionic surfactants such as glycerin fatty acid ester and biosurfactant (Alcaligenes Polysacchaides: Alkathylan, manufactured by Hakutosha; mannosyl sorbitol lipid: Surfmellow, manufactured by Toyobo Co., Ltd.) can be mentioned.
これらの両親媒性物質のうち、O/V/W乳化組成物の形成のしやすさから、好ましくはリン脂質が挙げられ、より好ましくはグリセロリン脂質、スフィンゴリン脂質である。
特に好ましくはホスファチジルコリン、ホスファチジルセリン、ホスファチジルエタノールアミン、ホスファチジルグリセロール、ホスファチジルイノシトール、スフィンゴリン脂質である。
Among these amphiphiles, phospholipids are preferable because of the ease of forming an O / V / W emulsion composition, and glycerophospholipids and sphingophospholipids are more preferable.
Particularly preferred are phosphatidylcholine, phosphatidylserine, phosphatidylethanolamine, phosphatidylglycerol, phosphatidylinositol and sphingophospholipid.
また本発明に用いるリン脂質は、動植物から抽出、精製した天然物であっても、化学合成したものであっても良く、水素添加、水酸化処理などの加工を施しても良い。天然物としては、大豆又は卵黄等からの抽出・精製物であるレシチンが、市販品の入手が容易であり、好ましい。 The phospholipid used in the present invention may be a natural product extracted and purified from animals and plants, or may be chemically synthesized, and may be subjected to processing such as hydrogenation or hydroxylation. As a natural product, lecithin, which is an extract / purified product from soybean or egg yolk, is preferable because it is easy to obtain a commercial product.
これらのレシチンうち、ホスファチジルコリンを70質量%(以下、単位%と略す)以上含有しているレシチンが好ましい。レシチン中のホスファチジルコリンの含有率は、薄層クロマトグラフィー(TLC)や高速液体クロマトフラフィー(HPLC)、イアトロスキャン(ヤトロン社製)等を用いた方法で分析することができる。例えば、特開2001−186898号公報に記載されるリン脂質が含まれる有機溶媒をTLCにスポットしてクロロホルム:メタノール:酢酸=65:25:10で展開し、50wt%硫酸エタノールを噴霧、加熱後デンシトメーターでリン脂質を分析する方法が挙げられる。前記方法以外でも、レシチン中に含まれるホフファチジルコリンの含有量、含有率を測定、算出できる方法であれば、いずれの方法でも良い。より好ましいレシチンは、ホスファチジルコリンを70%以上含有している大豆レシチン、卵黄レシチン、大豆レシチン水素添加物、卵黄レシチン水素添加物である。 Among these lecithins, lecithin containing phosphatidylcholine in an amount of 70% by mass (hereinafter abbreviated as “unit%”) or more is preferable. The content of phosphatidylcholine in lecithin can be analyzed by a method using thin layer chromatography (TLC), high performance liquid chromatography (HPLC), Iatroscan (manufactured by Yatron), or the like. For example, an organic solvent containing phospholipid described in JP-A-2001-186898 is spotted on TLC, developed with chloroform: methanol: acetic acid = 65: 25: 10, sprayed with 50 wt% ethanol sulfate, and after heating A method of analyzing phospholipids with a densitometer is mentioned. In addition to the above method, any method may be used as long as it can measure and calculate the content and content of phosphatidylcholine contained in lecithin. More preferable lecithin is soybean lecithin, egg yolk lecithin, soybean lecithin hydrogenated product, egg yolk lecithin hydrogenated product containing 70% or more of phosphatidylcholine.
ホスファチジルコリンを70%以上含有しているレシチンは市販されており、コートソームNC−21(水素添加大豆レシチン;日油社製)、レシノールS−10E、レシノールS−10EX(水素添加大豆レシチン;日光ケミカルズ社製)等を挙げることができる。 Lecithin containing 70% or more of phosphatidylcholine is commercially available, Coatsome NC-21 (hydrogenated soybean lecithin; manufactured by NOF Corporation), lecinol S-10E, lecinol S-10EX (hydrogenated soybean lecithin; Nikko Chemicals) For example).
両親媒性物質のO/V/W乳化組成物中における含有量は、O/V/W乳化組成物の総量を基準として0.0001〜20質量%が好ましく、さらに好ましくは0.0005〜15質量%であり、最も好ましくは0.001〜10質量%である。当該範囲内であれば、期待する十分な保湿効果が得られ、O/V/W乳化組成物の調製も容易である。 The content of the amphiphilic substance in the O / V / W emulsion composition is preferably 0.0001 to 20% by mass, more preferably 0.0005 to 15%, based on the total amount of the O / V / W emulsion composition. It is mass%, Most preferably, it is 0.001-10 mass%. If it is within this range, the expected sufficient moisturizing effect can be obtained, and the preparation of the O / V / W emulsion composition is easy.
本発明で用いられる(B)IOB値が0.2〜0.54で、融点が30℃以下の油分(括弧内はIOB値)としては、イソノナン酸イソノニル(0.2)、トリイソステアリン酸ポリオキシエチレングリセリル(0.2)、トリオレイン酸ポリオキシエチレングリセリル(0.2)、ジラウリン酸プロピレングリコール(0.22)、イソステアリン酸ポリオキシエチレンラウリルエーテル(2E.O.)(0.23)、ジステアリン酸エチレングリコール(0.23)、ジラウリン酸エチレングリコール(0.23)、トリ(カプリル酸・カプリン酸・ステアリン酸)グリセリル(0.23)、トリミリスチン酸ポリオキシエチレントリメチロールプロパン(0.23)、ジステアリン酸ジエチレングリコール(0.24)、トリイソステアリン酸ポリオキシエチレン硬化ヒマシ油(0.24)、トリステアリン酸ポリオキシエチレングリセリン(0.24)、パルミチン酸オクチル(0.24)、ジイソステアリン酸ジエチレングリコール(0.25)、ジオレイン酸ジエチレングリコール(0.25)、ジカプリン酸ネオペンチルグリコール(0.25)、ジカプリン酸プロピレングリコール(0.26)、ステアロイルグルタミン酸ジオクチルドデシル(0.26)、トリイソステアリン酸ポリグリセリル(0.26)、トリステアリン酸ポリオキシエチレントリメチロールプロパン(0.28)、メトキシケイヒ酸エチルヘキシル(0.28)、イソステアリルアルコール(0.29)、ジイソステアリン酸グリセリル(0.29)、ステアリン酸ポリオキシエチレンセチルエーテル(3E.O.)(0.29)、トリステアリン酸ポリオキシエチレングリセリン(0.29)、ラウロイルグルタミン酸ジオクチルドデシル(0.29)、ジステアリン酸ポリオキシエチレントリメチロールプロパン(0.3)、トリイソステアリン酸ポリオキシエチレングリセリル(0.3)、トリオレイン酸ポリオキシエチレングリセリル(0.3)、テトラオレイン酸ポリオキシエチレンソルビット(4E.O.)(0.31)、ジカプリル酸プロピレングリコール(0.32)、ジステアリン酸トリエチレングリコール(0.32)、ジステアリン酸ポリエチレングリコール(0.32)、ステアリン酸ポリオキシエチレンラウリルエーテル(3E.O.)(0.32)、N−ラウロイル−L−グルタミン酸ジ−2−ヘキシルデシル(0.33)、ジイソステアリン酸トリエチレングリコール(0.33)、ジオレイン酸トリエチレングリコール(0.33)、トリ(カプリル・カプリン酸)グリセリン(0.33)、トリイソステアリン酸ポリオキシエチレンソルビタン(4E.O.)(0.33)、トリオクタン酸トリメチロールプロパン(0.33)、トリステアリン酸ポリオキシエチレンソルビット(0.33)、リンゴ酸ジイソステアリル(0.33)、ジ−2−エチルへキサン酸ネオペンチルグリコール(0.34)、トリステアリン酸ポリオキシエチレングリセリン(0.34)、トリミリスチン酸ポリオキシエチレントリメチロールプロパン(0.34)、ジラウリン酸ジエチレングリコール(0.35)、ステアリン酸ポリオキシエチレンステアリルエーテル(4E.O.)(0.35)、テトラ2−エチルヘキサン酸ペンタエリスリット(0.35)、トリ2−エチルヘキサン酸グリセリル(0.35)、ジステアリン酸ポリオキシエチレントリメチロールプロパン(0.36)、トリイソステアリン酸ポリオキシエチレン硬化ヒマシ油(0.36)、乳酸オクチルドデシル(0.36)、ジステアリン酸ポリオキシエチレングリセリン(0.38)、ジネオペンタン酸メチルペンタンジオール(0.38)、モノイソステアリン酸ポリオキシエチレン硬化ヒマシ油(0.38)、モノステアリン酸プロピレングリコール(0.38)、オレイン酸プロピレングリコール(0.39)、ジステアリン酸ポリエチレングリコール(0.39)、ミリストイルメチルアミノプロピオン酸ヘキシルデシル(0.39)、モノオレイン酸プロピレングリコール(0.39)、イソステアリン酸プロピレングリコール(0.4)、ジイソステアリン酸ポリエチレングリコール(4E.O.)(0.4)、ジオレイン酸ポリエチレングリコール(0.4)、ジステアリン酸ポリグリセリル(0.4)、モノステアリン酸エチレングリコール(0.4)、ラウロイルグルタミン酸ポリオキシエチレンオクチルドデシルエーテルジエステル(0.4)、ジイソステアリン酸ポリグリセリル(0.41)、乳酸オクチルドデシル(0.41)、ジステアリン酸ポリオキシエチレントリメチロールプロパン(0.42)、ラウロイルグルタミン酸ポリオキシエチレンステアリルエーテルジエステル(0.42)、ステアリン酸ポリオキシエチレンセチルエーテル(5E.O.)(0.43)、ジネオペンタン酸ジエチルペンタンジオール(0.44)、ポリオキシエチレンステアリルエーテル(0.44)、ジラウリン酸トリエチレングリコール(0.45)、ジ−2−エチルヘキサン酸ネオペンチルグリコール(0.47)、ステアリン酸ポリオキシエチレンステアリルエーテル(6E.O.)(0.47)、トリイソステアリン酸ポリオキシエチレン硬化ヒマシ油(0.47)、親油型モノステアリン酸グリセリン(0.47)、イソステアリン酸ポリオキシエチレンラウリルエーテル(5E.O.)(0.48)、ステアリン酸ポリオキシエチレンラウリルエーテル(5E.O.)(0.48)、トリステアリン酸ポリオキシエチレントリメチロールプロパン(0.48)、ポリオキシエチレンセチルエーテル(0.49)、トリオレイン酸ポリオキシエチレングリセリル(0.5)、トリステアリン酸ポリオキシエチレングリセリン(0.5)、ポリオキシエチレン・メチルポリシロキサン共重合体(0.5)、ジステアリン酸ポリグリセリル(0.51)、トリイソステアリン酸ポリオキシエチレングリセリル(0.51)、ポリオキシエチレン硬化ヒマシ油(0.51)、ジイソステアリン酸ポリグリセリル(0.52)、ジオレイン酸ポリエチレングリコール(0.52)、ジステアリン酸ポリエチレングリコール(0.52)、トリイソステアリン酸ポリグリセリル(0.52)、ジイソステアリン酸ポリエチレングリコール(6E.O.)(0.53)、パルミチン酸グリセリン(0.53)、モノステアリン酸ポリエチレングリコール(0.53)、ラウリン酸プロピレングリコール(0.53)、イソステアリルグリセリルエーテル(0.54)、ジラウリン酸ポリエチレングリコール(0.54)、モノイソステアリン酸ポリオキシエチレン硬化ヒマシ油(0.54)等が挙げられる。 (B) The oil component having an IOB value of 0.2 to 0.54 and a melting point of 30 ° C. or less (IOB value in parentheses) used in the present invention is isononyl isononanoate (0.2), polyisoisostearate poly Oxyethylene glyceryl (0.2), polyoxyethylene glyceryl trioleate (0.2), propylene glycol dilaurate (0.22), isostearic acid polyoxyethylene lauryl ether (2E.O.) (0.23) , Ethylene glycol distearate (0.23), ethylene glycol dilaurate (0.23), tri (caprylic acid / capric acid / stearic acid) glyceryl (0.23), trimyristate polyoxyethylene trimethylolpropane (0 .23), diethylene glycol distearate (0.24), triisostearate Polyoxyethylene hydrogenated castor oil (0.24), polyoxyethylene glyceryl tristearate (0.24), octyl palmitate (0.24), diethylene glycol diisostearate (0.25), diethylene glycol dioleate (0 .25), neopentyl glycol dicaprate (0.25), propylene glycol dicaprate (0.26), dioctyldodecyl stearoyl glutamate (0.26), polyglyceryl triisostearate (0.26), polyoxytristearate Ethylene trimethylolpropane (0.28), ethylhexyl methoxycinnamate (0.28), isostearyl alcohol (0.29), glyceryl diisostearate (0.29), polyoxyethylene acetate stearate Ruether (3E.O.) (0.29), polyoxyethylene glyceryl tristearate (0.29), dioctyldodecyl lauroyl glutamate (0.29), polyoxyethylene trimethylolpropane distearate (0.3), Polyoxyethylene glyceryl triisostearate (0.3), polyoxyethylene glyceryl trioleate (0.3), polyoxyethylene sorbitol tetraoleate (4EO) (0.31), propylene glycol dicaprylate ( 0.32), triethylene glycol distearate (0.32), polyethylene glycol distearate (0.32), polyoxyethylene lauryl ether stearate (3EO) (0.32), N-lauroyl-L -Di-2-hexyl glutamate Sildecyl (0.33), triethylene glycol diisostearate (0.33), triethylene glycol dioleate (0.33), tri (caprylic / capric) glycerin (0.33), polyoxyethylene sorbitan triisostearate (4E. O. ) (0.33), trimethylolpropane trioctanoate (0.33), polyoxyethylene sorbite tristearate (0.33), diisostearyl malate (0.33), di-2-ethylhexanoic acid Neopentyl glycol (0.34), polyoxyethylene glycerin tristearate (0.34), polyoxyethylene trimethylolpropane trimyristate (0.34), diethylene glycol dilaurate (0.35), polyoxystearate Ethylene stearyl ether (4E.O.) (0.35), tetra-2-ethylhexanoic acid pentaerythritol (0.35), glyceryl tri-2-ethylhexanoate (0.35), distearate polyoxyethylene trimethylol Propane (0.36), triisostearic acid Reoxyethylene hydrogenated castor oil (0.36), octyldodecyl lactate (0.36), polyoxyethylene glyceryl distearate (0.38), methylpentanediol dineopentanoate (0.38), polyoxyethylene monoisostearate Hydrogenated castor oil (0.38), propylene glycol monostearate (0.38), propylene glycol oleate (0.39), polyethylene glycol distearate (0.39), hexyldecyl myristoylmethylaminopropionate (0. 39), propylene glycol monooleate (0.39), propylene glycol isostearate (0.4), polyethylene glycol diisostearate (4EO) (0.4), polyethylene glycol dioleate (0.4), Polyglyceryl stearate (0.4), ethylene glycol monostearate (0.4), lauroyl glutamic acid polyoxyethylene octyldodecyl ether diester (0.4), polyglyceryl diisostearate (0.41), octyldodecyl lactate (0. 41), polyoxyethylene trimethylolpropane distearate (0.42), polyoxyethylene stearyl ether diester (0.42) lauroyl glutamic acid, polyoxyethylene cetyl ether stearate (5E.O.) (0.43), Dineopentanic acid diethylpentanediol (0.44), polyoxyethylene stearyl ether (0.44), dilauric acid triethylene glycol (0.45), di-2-ethylhexanoic acid neopentylglycol (0.47), polyoxyethylene stearyl ether stearate (6E. O. (0.47), polyoxyethylene hydrogenated castor oil (0.47), lipophilic glyceryl monostearate (0.47), polyoxyethylene lauryl ether (5E.O.) (0 .48), polyoxyethylene lauryl ether stearate (5EO) (0.48), polyoxyethylene trimethylolpropane tristearate (0.48), polyoxyethylene cetyl ether (0.49), trio Polyoxyethylene glyceryl oleate (0.5), polyoxyethylene glyceryl tristearate (0.5), polyoxyethylene methylpolysiloxane copolymer (0.5), polyglyceryl distearate (0.51), Polyoxyethylene glyceryl triisostearate (0.51) Polyoxyethylene hydrogenated castor oil (0.51), polyglyceryl diisostearate (0.52), polyethylene glycol dioleate (0.52), polyethylene glycol distearate (0.52), polyglyceryl triisostearate (0.52) , Polyethylene glycol diisostearate (6EO) (0.53), glyceryl palmitate (0.53), polyethylene glycol monostearate (0.53), propylene glycol laurate (0.53), isostearyl glyceryl Examples include ether (0.54), polyethylene glycol dilaurate (0.54), and polyoxyethylene hydrogenated castor oil (0.54) monoisostearate.
使用感の点から、好ましいIOB値が0.2〜0.54で、融点が30℃以下の油分としては、イソノナン酸イソノニル、ジカプリン酸プロピレングリコール、イソステアリルアルコール、ジカプリン酸プロピレングルコール、トリオクタン酸トリメチロールプロパン、乳酸オクチルドデシル、ジイソステアリン酸ポリグリセリル、トリイソステアリン酸ポリグリセリル、イソステアリルグリセリルエーテル、下記一般式(1)で表されるプロピレングリコールモノエステルが挙げられる。 From the viewpoint of feeling of use, an oil component having a preferred IOB value of 0.2 to 0.54 and a melting point of 30 ° C. or less includes isononyl isononanoate, propylene glycol dicaprate, isostearyl alcohol, propylene glycol dicaprate, trioctanoic acid Examples thereof include trimethylolpropane, octyldodecyl lactate, polyglyceryl diisostearate, polyglyceryl triisostearate, isostearyl glyceryl ether, and propylene glycol monoester represented by the following general formula (1).
(式中、R1は、炭素数9〜23の直鎖状若しくは分岐鎖状の、飽和若しくは不飽和の炭化水素基を示す) (In the formula, R 1 represents a linear or branched, saturated or unsaturated hydrocarbon group having 9 to 23 carbon atoms)
これらの油分のうち、特に水分蒸散抑制効果及び使用感に優れた効果を得る点から、前記一般式(1)で表されるプロピレングリコールモノエステルのR1が炭素数15〜19の直鎖状若しくは分岐鎖状の、飽和若しくは不飽和の炭化水素基のものが好ましく、イソステアリン酸プロピレングリコール、オレイン酸プロピレングリコールが好適に挙げられる。 Among these oils, R 1 of the propylene glycol monoester represented by the general formula (1) is a straight chain having 15 to 19 carbon atoms, particularly from the viewpoint of obtaining the effect of suppressing moisture transpiration and the feeling of use. Or a branched, saturated or unsaturated hydrocarbon group is preferable, and propylene glycol isostearate and propylene glycol oleate are preferable.
これらの油分のO/V/W乳化組成物中における含有量は0.05〜60質量%が好ましく、より好ましくは0.1〜40質量%、最も好ましくは0.1〜20質量%である。
当該範囲内であれば、優れた水分蒸散抑制効果が得られ、乳化組成物の調製も容易であるため好ましい。
The content of these oils in the O / V / W emulsion composition is preferably 0.05 to 60% by mass, more preferably 0.1 to 40% by mass, and most preferably 0.1 to 20% by mass. .
If it is in the said range, since the outstanding moisture transpiration suppression effect is acquired and preparation of an emulsion composition is also easy, it is preferable.
尚、O/V/W乳化組成物中に(B)IOB値が0.20〜0.54で、融点が30℃以下の油分以外の油分を実質的に含有しないものが乳化組成物の調製上、好ましいが、成分(B)以外の油分も、成分(B)100質量部に対し、5質量部以下であれば含有していても構わない。 In the O / V / W emulsion composition, (B) an IOB value of 0.20 to 0.54 and a melting point of 30 ° C. or less and an oil component other than an oil component is substantially not included. Although it is preferable, oil components other than the component (B) may be contained as long as they are 5 parts by mass or less with respect to 100 parts by mass of the component (B).
本発明の(A)両親媒性物質と(B)IOB値が0.20〜0.54で、融点が30℃以下の油分の含有質量比率〔A/B〕は、優れた水分蒸散効果及び良好な使用感を得る点から、1/0.05〜1/2000が好ましく、さらに好ましくは1/0.1〜1/100であり、特に好ましくは1/0.5〜1/50である。 The (A) amphiphile and (B) IOB value of the present invention is 0.20 to 0.54, and the content mass ratio [A / B] of the oil having a melting point of 30 ° C. or less is an excellent moisture transpiration effect and From the point of obtaining a good feeling of use, 1 / 0.05 to 1/2000 is preferable, more preferably 1 / 0.1 to 1/100, and particularly preferably 1 / 0.5 to 1/50. .
本発明のO/V/W乳化組成物には、両親媒性物質の分散性を向上させ、使用感を向上させるため、(C)多価アルコールをさらに併用する。好ましい多価アルコールとしては、エチレングリコール、ジエチレングリコール、トリエチレングリコール、ポリエチレングリコール(平均分子量1000未満)、プロピレングリコール、ジプロピレングリコール、ポリプロピレングリコール(平均分子量:1000未満)、グリセリン、ジグリセリン、ポリグリセリン、イソプレングリコール、1,2ペンタンジオール、1,3−ブチレングリコール、ヘキシレングリコール等を挙げることができる。このうち、イソプレングリコール、1,2ペンタンジオール、1,3−ブチレングリコール、ジプロピレングリコール、ヘキシレングリコールが特に好ましい。 In the O / V / W emulsion composition of the present invention, (C) a polyhydric alcohol is further used in combination in order to improve the dispersibility of the amphiphile and improve the feeling of use. Preferred polyhydric alcohols include ethylene glycol, diethylene glycol, triethylene glycol, polyethylene glycol (average molecular weight less than 1000), propylene glycol, dipropylene glycol, polypropylene glycol (average molecular weight: less than 1000), glycerin, diglycerin, polyglycerin, Examples include isoprene glycol, 1,2 pentanediol, 1,3-butylene glycol, hexylene glycol and the like. Of these, isoprene glycol, 1,2 pentanediol, 1,3-butylene glycol, dipropylene glycol, and hexylene glycol are particularly preferable.
(C)多価アルコールのO/V/W乳化組成物中における含有量は、1〜10質量%が好ましく、より好ましくは2〜9質量%であり、さらに好ましくは3〜8質量%である。
当該範囲内であれば、ベシクルの分散性が良好で、分離・凝集等がなく、また使用感としてのび・なめらかさに優れる。
(C) 1-10 mass% is preferable, as for content in the O / V / W emulsion composition of a polyhydric alcohol, More preferably, it is 2-9 mass%, More preferably, it is 3-8 mass%. .
Within this range, the vesicles have good dispersibility, no separation / aggregation, etc., and they are excellent in feeling of use and smoothness.
本発明の乳化組成物における、(A)両親媒性物質と(C)多価アルコールの含有質量比率〔A/C〕は、O/V/W乳化組成物の分離・凝集等がなく、製造性の良さの点から、1:12000〜4:1が好ましく、さらに好ましくは1:5200〜1:3.5である。 In the emulsified composition of the present invention, the mass ratio [A / C] of (A) amphiphile and (C) polyhydric alcohol is not produced by separation / aggregation of the O / V / W emulsified composition. From the point of good quality, 1: 12000-4: 1 are preferable, More preferably, it is 1: 5200-1: 3.5.
また、本発明の乳化組成物には、(D)水性成分(前記、(C)多価アルコールは除く)が含まれる。当該水性成分としては、水、アルコール、水溶性高分子、水酸化物等が挙げられる。水性成分の乳化組成物中における含有量は、20〜98.9499質量%が好ましく、より好ましくは、36〜97.8995質量%、さらに好ましくは62〜96.899質量%である。 The emulsified composition of the present invention contains (D) an aqueous component (excluding the (C) polyhydric alcohol). Examples of the aqueous component include water, alcohol, water-soluble polymer, hydroxide and the like. The content of the aqueous component in the emulsified composition is preferably 20 to 98.9499% by mass, more preferably 36 to 97.8895% by mass, and still more preferably 62 to 96.899% by mass.
水性成分のアルコールは、前記(C)多価アルコールを除く、ヒドロキシル基を有する化合物であり、任意成分として配合することができる。好ましくは炭素数2〜8の低級アルコールが挙げられ、エタノール、プロパノール、イソプロパノール、ブチルアルコール、イソブチルアルコール、ペンタノール、ヘキサノール、ヘプタノール、オクタノール、フェノール、クレゾール、シクロヘキサノール、メチルシクロヘキサノール、ベンジルアルコール、フェノキシエタノール等が挙げられる。
当該アルコールを、O/V/W乳化組成物中に配合する場合、当該乳化組成物中における含有量は、5質量%以下が好ましく、より好ましくは3質量%以下である。当該範囲内であれば、本願の、O/V/W乳化組成物が形成に影響がなく、好ましい。
The alcohol of the aqueous component is a compound having a hydroxyl group, excluding the (C) polyhydric alcohol, and can be blended as an optional component. Preferred examples include lower alcohols having 2 to 8 carbon atoms, such as ethanol, propanol, isopropanol, butyl alcohol, isobutyl alcohol, pentanol, hexanol, heptanol, octanol, phenol, cresol, cyclohexanol, methylcyclohexanol, benzyl alcohol, phenoxyethanol. Etc.
When mix | blending the said alcohol in an O / V / W emulsion composition, 5 mass% or less is preferable in the said emulsion composition, More preferably, it is 3 mass% or less. If it is in the said range, the O / V / W emulsion composition of this application has no influence on formation, and is preferable.
水性成分の水溶性高分子は任意成分として配合することができ、カルボキシビニルポリマー、アクリル酸・メタクリル酸アルキル共重合体、キサンタンガム、ヒドロキシプロピルメチルセルロース、ポリアクリルアミド、(アクリル酸Na/アクリロイルジメチルタウリンNa)コポリマー、ヒアルロン酸及びそのアルカリ金属塩等が挙げられる。
当該水溶性高分子を、O/V/W乳化組成物中に配合する場合、当該乳化組成物中における含有量は、0.1〜2質量%が好ましく、より好ましくは0.1〜1質量%である。
当該範囲内であれば、使用感が良好で、水分蒸散抑制効果が得られ、好ましい。
The water-soluble polymer of the aqueous component can be blended as an optional component, such as carboxyvinyl polymer, acrylic acid / alkyl methacrylate copolymer, xanthan gum, hydroxypropylmethylcellulose, polyacrylamide, (Na acrylate / acryloyl dimethyl taurine Na) Examples thereof include copolymers, hyaluronic acid and alkali metal salts thereof.
When mix | blending the said water-soluble polymer in an O / V / W emulsion composition, 0.1-2 mass% is preferable in the said emulsion composition, More preferably, it is 0.1-1 mass. %.
If it is in the said range, a usability | use_condition is favorable and the moisture evaporation suppression effect is acquired and it is preferable.
水性成分の水酸化物は任意成分として配合することができ、水酸化カリウム、水酸化カルシウム等の水酸化金属塩等が挙げられる。
当該水酸化物を、O/V/W乳化組成物中に配合する場合、当該乳化組成物中における含有量は、1質量%以下が好ましく、より好ましくは0.5質量%以下である。当該範囲内であれば、本願の、O/V/W乳化組成物の形成に影響がなく、好ましい。
The aqueous component hydroxide can be blended as an optional component, and examples thereof include metal hydroxide salts such as potassium hydroxide and calcium hydroxide.
When mix | blending the said hydroxide in an O / V / W emulsion composition, 1 mass% or less is preferable in the said emulsion composition, More preferably, it is 0.5 mass% or less. If it is in the said range, there will be no influence on formation of the O / V / W emulsion composition of this application, and it is preferable.
本発明のO/V/W乳化組成物は、単に油分が両親媒性物質により乳化されている形態ではなく、水性成分が連続相であり、ベシクル被覆油性粒子が分散相となる乳化組成物である。ここで、ベシクル被覆油性粒子は、油分と水性成分との油水界面上で、(A)両親媒性物質と、界面近傍の(B)油分の一部等からベシクルが形成され、そのベシクルによって残りの(B)油分の表面が覆われた油性粒子である。
前記ベシクル被覆油性粒子を分散相に含有するO/V/W乳化系を採ることにより、多量の油分を安定に含有する乳化組成物となり、優れた水分蒸散抑制効果と、優れた使用感が得られるものと考えられる。このような乳化系を形成していることは、微分干渉顕微鏡像及び偏光顕微鏡像により確認することができる。
The O / V / W emulsion composition of the present invention is not simply a form in which oil is emulsified with an amphiphilic substance, but an emulsion composition in which an aqueous component is a continuous phase and vesicle-coated oily particles are a dispersed phase. is there. Here, the vesicle-coated oily particles are formed on the oil-water interface between the oil component and the aqueous component, and the vesicle is formed from (A) an amphiphilic substance and (B) a part of the oil component in the vicinity of the interface, and the vesicles remain. (B) Oily particles with the oily surface covered.
By adopting an O / V / W emulsification system containing the vesicle-coated oily particles in the dispersed phase, it becomes an emulsified composition that stably contains a large amount of oil, and has an excellent moisture transpiration control effect and excellent usability. It is thought that The formation of such an emulsification system can be confirmed by a differential interference microscope image and a polarization microscope image.
本発明の油水界面上に形成されるベシクルの平均粒子径は、製造効率の点から0.5〜10μmの範囲が好ましく、より好ましく1〜5μmの範囲である。また、ベシクル被覆油性粒子の平均粒子径は、油分表面をベシクルが均一に被覆した状態であれば、特に制限されないが、製造効率の点から5〜80μmの範囲に調整することが好ましく、より好ましくは10〜60μm、最も好ましくは15〜40μmの範囲である。尚、平均粒子径は、任意の視野の任意の粒子20個について、微分干渉顕微鏡写真の同視野中の粒子径を読み取り、読み取れるすべての粒子の直径の算術平均より求め、小数点以下を四捨五入した値とした。 The average particle size of vesicles formed on the oil / water interface of the present invention is preferably in the range of 0.5 to 10 μm, more preferably in the range of 1 to 5 μm from the viewpoint of production efficiency. Further, the average particle size of the vesicle-coated oily particles is not particularly limited as long as the vesicle is uniformly coated on the oil surface, but it is preferable to adjust to the range of 5 to 80 μm from the viewpoint of production efficiency, and more preferable. Is in the range of 10-60 μm, most preferably 15-40 μm. The average particle diameter is a value obtained by reading the particle diameter in the same field of the differential interference micrograph for any 20 particles in an arbitrary field of view, calculating from the arithmetic average of the diameters of all the particles that can be read, and rounding off the decimals. It was.
本発明のO/V/W乳化組成物を製造するためには、油分と水性成分との油水界面上で、(A)両親媒性物質と、界面近傍の(B)油分の一部からなるベシクルを形成させる事が必要である。そのため、本発明のO/V/W乳化組成物を、(1)(A)両親媒性物質、(B)油分及び(C)多価アルコールを相転移温度以上に加熱し、均一に混合させた後、(2)相転移温度以上で水性成分と混合し、その後、(3)相転移温度以下に冷却して製造する方法が挙げられる。 In order to produce the O / V / W emulsion composition of the present invention, it comprises (A) an amphiphilic substance and (B) a part of oil in the vicinity of the interface on the oil / water interface between the oil and the aqueous component. It is necessary to form vesicles. Therefore, the O / V / W emulsified composition of the present invention (1) (A) amphiphile, (B) oil and (C) polyhydric alcohol is heated to the phase transition temperature or higher and mixed uniformly. Thereafter, (2) mixing with an aqueous component at a phase transition temperature or higher and then (3) cooling to the phase transition temperature or lower for production.
両親媒性物質として好ましいリン脂質を用いた場合、本発明のO/V/W乳化組成物を効率良く形成させるためには、(1)(A)両親媒性物質、(B)油分及び(C)多価アルコールを70〜90℃の範囲に加熱し、均一に混合させた後、70〜90℃の範囲(好ましくは、油性成分と同一温度)で水性成分と混合し、その後、(3)40℃以下に冷却して製造する方法が挙げられる。 When a preferred phospholipid is used as an amphiphilic substance, in order to efficiently form the O / V / W emulsion composition of the present invention, (1) (A) an amphiphilic substance, (B) an oil component and ( C) The polyhydric alcohol is heated in the range of 70 to 90 ° C. and uniformly mixed, and then mixed with the aqueous component in the range of 70 to 90 ° C. (preferably at the same temperature as the oily component). ) A method of cooling to 40 ° C. or lower for production.
(A)両親媒性物質、(C)多価アルコール及び(D)水性成分を相転移温度以上で混合し、ベシクル(リポソーム)を作成した後、相転移温度以下で本発明に用いられる(B)油分を添加して混合させた場合、ベシクルと油分がそれぞれ単独に分散した組成物となり、ベシクルが油分を被覆した油性粒子を形成できない。 (A) Amphiphile, (C) Polyhydric alcohol and (D) Aqueous component are mixed at or above the phase transition temperature to prepare vesicles (liposomes), and then used in the present invention at or below the phase transition temperature (B ) When an oil component is added and mixed, a composition in which the vesicle and the oil component are separately dispersed is obtained, and the vesicle cannot form oily particles coated with the oil component.
特に両親媒性物質がリン脂質である場合、相転移温度はリン脂質を構成する脂肪酸鎖長、不飽和度、親水基の種類等によって大きく異なるが、相転移温度以下ではアシル鎖の運動が抑制され流動性がないゲル状であり、相転移温度以上では流動性の増した液晶状態となる。従って、相転移温度以上にすることで、効率良く、本発明のO/V/W乳化組成物を形成できるものと考えられる。 In particular, when the amphiphile is a phospholipid, the phase transition temperature varies greatly depending on the length of the fatty acid chain constituting the phospholipid, the degree of unsaturation, the type of hydrophilic group, etc., but the movement of the acyl chain is suppressed below the phase transition temperature. It is in the form of a gel with no fluidity and becomes a liquid crystal state with increased fluidity above the phase transition temperature. Therefore, it is considered that the O / V / W emulsion composition of the present invention can be efficiently formed by setting the phase transition temperature or higher.
尚、相転移温度とは、ゲル状態から液晶状態へ変化する際の温度であり、その測定は、示差走査熱量計(DSC)、具体的にはDSC120(セイコー電子工業株式会社製)等を用いて行い、得られたDSC昇温曲線において観測された吸熱ピークの頂点の温度を相転移温度とすることができる。 The phase transition temperature is a temperature when changing from a gel state to a liquid crystal state, and the measurement is performed using a differential scanning calorimeter (DSC), specifically, DSC 120 (manufactured by Seiko Denshi Kogyo Co., Ltd.). The temperature at the top of the endothermic peak observed in the obtained DSC temperature rise curve can be used as the phase transition temperature.
ベシクル被覆油性粒子の製剤安定性は高く、ベシクル被覆油性粒子を形成した後であれば、本発明のO/V/W乳化組成物を、油分、有機酸類、アルカリ類、界面活性剤、紫外線吸収剤、粉体、顔料、染料、防腐・防カビ剤、酸化防止剤、キレート剤、増粘剤、香料、及び医薬品、医薬部外品、化粧料等に通常用いられる成分を含有する組成物中に、本発明の効果を損なわない範囲で適宜配合することができる。これらは、乳液、クリーム、ゲル等の皮膚外用剤として、特に化粧料、医薬品の用途に適用するのが好ましい。 The formulation stability of the vesicle-coated oily particles is high, and after the vesicle-coated oily particles are formed, the O / V / W emulsion composition of the present invention is oily, organic acids, alkalis, surfactants, UV absorbing. In a composition containing ingredients commonly used in agents, powders, pigments, dyes, antiseptic / antifungal agents, antioxidants, chelating agents, thickeners, fragrances, and pharmaceuticals, quasi drugs, cosmetics, etc. In the range which does not impair the effect of this invention, it can mix | blend suitably. These are preferably applied as skin external preparations such as emulsions, creams, gels, etc., especially for cosmetics and pharmaceuticals.
本発明のO/V/W乳化組成物を含有する化粧料の剤形は特に制限されないが、O/V/W乳化組成物が油分を安定に配合できる利点を考慮すると、水性化粧料、乳化化粧料(O/W型、W/O型、W/O/W型等)に好ましく利用できる。 The dosage form of the cosmetic containing the O / V / W emulsion composition of the present invention is not particularly limited. However, considering the advantage that the O / V / W emulsion composition can stably contain oil, an aqueous cosmetic and emulsion It can be preferably used for cosmetics (O / W type, W / O type, W / O / W type, etc.).
本発明のO/V/W乳化組成物を化粧料中に添加する場合、O/V/W乳化組成物の化粧料中の含有量は、使用感等を考慮し適宜選択することができるが、良好な使用性(べたつき感、保湿感)の点から、化粧料100質量部に対し、5〜95質量部が好ましく、より好ましくは20〜80質量部である。 When the O / V / W emulsion composition of the present invention is added to a cosmetic, the content of the O / V / W emulsion composition in the cosmetic can be appropriately selected in consideration of the feeling of use and the like. From the viewpoint of good usability (stickiness, moisturizing feeling), the amount is preferably 5 to 95 parts by mass, more preferably 20 to 80 parts by mass with respect to 100 parts by mass of the cosmetic.
以下、実施例及び比較例に基づいて本発明を詳細に説明する。尚、本発明はこれらの例に限定されるものではない。 Hereinafter, the present invention will be described in detail based on examples and comparative examples. The present invention is not limited to these examples.
実施例1〜21及び比較例1〜6
表1、表2及び表3に従い、下記の製法で作成したO/V/W乳化組成物の顕微鏡観察を行い、O/V/W乳化組成物の構造を確認した。また、乳化組成物の使用感について、下記評価基準に基づき、評価を行った。評価結果を合わせて、表1及び表2に記載する。
尚、水素添加大豆リン脂質は、ホスファチジルコリンを95質量%以上含有するコートソームNC−21(水素添加大豆レシチン;日油社製)を用いた。
Examples 1-21 and Comparative Examples 1-6
According to Table 1, Table 2, and Table 3, the O / V / W emulsion composition prepared by the following production method was observed with a microscope, and the structure of the O / V / W emulsion composition was confirmed. Moreover, the usability of the emulsified composition was evaluated based on the following evaluation criteria. The evaluation results are shown in Table 1 and Table 2.
As the hydrogenated soybean phospholipid, Coatsome NC-21 (hydrogenated soybean lecithin; manufactured by NOF Corporation) containing 95% by mass or more of phosphatidylcholine was used.
(組成物観察の評価方法)
微分干渉顕微鏡及び偏光顕微鏡(共にECLIPSE80i、ニコン社製)により組成物の観察を行い、ベシクルが油分を被覆した乳化組成物(具体的には図1又は図2に示す)が確認できるか否かにより判定を行なった。
(Evaluation method for composition observation)
The composition is observed with a differential interference microscope and a polarizing microscope (both ECLIPSE 80i, manufactured by Nikon Corporation), and whether or not an emulsified composition in which the vesicle is coated with oil (specifically, shown in FIG. 1 or 2) can be confirmed. Judgment was carried out.
○:ベシクルが油分を被覆した組成物を確認できる。
×:ベシクルが油分を被覆した組成物を確認できない。
○: A composition in which the vesicles are coated with oil can be confirmed.
X: The composition which the vesicle coat | covered the oil component cannot be confirmed.
(使用感の評価方法)
専門評価パネラー10名により、使用感及び保湿感に関する評価として、べたつきのなさ、しっとり感について5段階評価し、平均点を算出することにより判定した。
(Evaluation method of usability)
Ten professional evaluation panelists evaluated the feeling of use and moisturizing feeling on a non-sticky and moist feeling basis on a five-point scale, and determined by calculating the average score.
(5段階評価)
5点:非常に良い。
4点:良い。
3点:普通。
2点:やや悪い。
1点:悪い。
(5-level evaluation)
5 points: Very good.
4 points: Good.
3 points: Normal.
2 points: Somewhat bad.
1 point: Bad.
A.成分(1)〜(17)を80℃に加熱し、均一溶解する。
B.成分(18)〜(21)を70℃に加熱し、均一溶解する。
C.BにAを添加して攪拌し、25℃に冷却後、組成物を得た。
A. Components (1) to (17) are heated to 80 ° C. and uniformly dissolved.
B. Ingredients (18) to (21) are heated to 70 ° C. and uniformly dissolved.
C. A was added to B and stirred, and after cooling to 25 ° C., a composition was obtained.
微分干渉顕微鏡による観察から、図1に示すように、本発明のO/V/W乳化組成物中には、粒子径3〜4μmのベシクルが、油分に被覆された粒子径が5〜40μmのベシクル被覆油性粒子が形成されていた。偏光顕微鏡による観察から、ベシクル中心部が明るく表示されており、ベシクルが形成されていることが分かる。
これは、油分と水性成分との油水界面上で、(A)両親媒性物質と、界面近傍の(B)油分の一部からベシクルが形成され、そのベシクルによって残りの(B)油分の表面が覆われることでベシクル被覆油性粒子が形成されているものと推測される。
From observation with a differential interference microscope, as shown in FIG. 1, in the O / V / W emulsified composition of the present invention, a vesicle having a particle size of 3 to 4 μm and a particle size of 5 to 40 μm coated with oil are contained. Vesicle-coated oily particles were formed. From observation with a polarizing microscope, the center of the vesicle is brightly displayed, and it can be seen that the vesicle is formed.
This is because a vesicle is formed from (A) an amphiphile and a part of (B) oil in the vicinity of the interface on the oil / water interface between the oil and the aqueous component, and the surface of the remaining (B) oil is formed by the vesicle. It is presumed that vesicle-coated oily particles are formed by being covered.
また、表1及び表2の結果より、O/V/W乳化組成物は、保湿感に優れ、さらに使用感(べたつき感のなさ)の良好なものであった。 Moreover, from the results of Tables 1 and 2, the O / V / W emulsion composition was excellent in moisturizing feeling and in good usability (no stickiness).
実施例8及び比較例7
下記製造方法にて作成した比較例7について、上記と同様に顕微鏡観察を行い、水相にベシクルと油分がそれぞれ分散し、ベシクルが油分を被覆した組成物ではないことを確認した。次に実施例8作成した組成物、及び比較例7の組成物の水分蒸散抑制効果について評価を行った。評価結果を図3に記載する。
尚、水素添加大豆リン脂質は、ホスファチジルコリンを95質量%以上含有するコートソームNC−21(水素添加大豆レシチン;日油社製)を用いた。
Example 8 and Comparative Example 7
About the comparative example 7 created with the following manufacturing method, the microscope observation was performed similarly to the above, and it confirmed that the vesicle and the oil component were disperse | distributed to the water phase, respectively, and the vesicle was not the composition which coat | covered the oil component. Next, the water evaporation suppression effect of the composition prepared in Example 8 and the composition of Comparative Example 7 was evaluated. The evaluation results are shown in FIG.
As the hydrogenated soybean phospholipid, Coatsome NC-21 (hydrogenated soybean lecithin; manufactured by NOF Corporation) containing 95% by mass or more of phosphatidylcholine was used.
(水分蒸散抑制効果の評価方法)
1.実施例8、及び比較例7のサンプル10μlを親水性メンブランフィルター(MF−ミリポア GSWP02500、日本ミリポア社製;孔径0.22μm、フィルター直径25mm)上に塗布し、32℃ホットプレート上で20分間乾燥させた。
2.フランツ拡散セル(有効面積:0.95cm2)に純水5mLを加え、試料の乾燥膜を形成させた各メンブランフィルター及び何も塗布していないメンブランフィルターにより蓋をし、室温32℃、湿度20%の恒温槽に移した。
3.6時間後にフランツ拡散セルを恒温槽より取り出し、重量変化(水分蒸散量)を測定した。
4.各サンプルの重量変化量を、何も塗布していないメンブランフィルターで蓋をした試料の重量変化量で割った値を水分蒸散抑制率として評価を行った。
(Evaluation method of moisture transpiration suppression effect)
1. 10 μl of the sample of Example 8 and Comparative Example 7 was applied on a hydrophilic membrane filter (MF-Millipore GSWP02500, manufactured by Nippon Millipore; pore diameter 0.22 μm, filter diameter 25 mm) and dried on a 32 ° C. hot plate for 20 minutes. I let you.
2. 5 mL of pure water is added to a Franz diffusion cell (effective area: 0.95 cm 2 ), and each membrane filter on which a dry film of the sample is formed and covered with an uncoated membrane filter, room temperature 32 ° C., humidity 20 %.
After 3.6 hours, the Franz diffusion cell was taken out of the thermostatic bath, and the weight change (moisture transpiration amount) was measured.
4). A value obtained by dividing the weight change amount of each sample by the weight change amount of the sample covered with a membrane filter to which nothing was applied was evaluated as a moisture transpiration suppression rate.
(調製方法)比較例7
実施例8の処方にて、成分(10)を添加するタイミングを変えた
A.成分(1)、(17)を80℃に加熱し、均一溶解する。
B.成分(18)〜(21)を70℃に加熱し、均一溶解する。
C.BにAを添加して攪拌し、室温まで冷却した。
D.Cに(10)を室温で加えて攪拌し、組成物を得た。
(Preparation method) Comparative Example 7
In the formulation of Example 8, the timing of adding the component (10) was changed. Ingredients (1) and (17) are heated to 80 ° C. and dissolved uniformly.
B. Ingredients (18) to (21) are heated to 70 ° C. and uniformly dissolved.
C. A was added to B, stirred, and cooled to room temperature.
D. (10) was added to C at room temperature and stirred to obtain a composition.
図3に示すとおり、本発明のO/V/W乳化組成物は水分蒸散抑制効果に優れたものであった。すなわち、ベシクル被覆油性粒子を分散相とするO/V/W乳化組成物(実施例8)は、同一組成でベシクルと油分が独立に分散して存在するO/W乳化組成物(比較例7)と比べ、優れた水分蒸散抑制効果が得られることが分かった。 As shown in FIG. 3, the O / V / W emulsion composition of the present invention was excellent in moisture transpiration suppression effect. That is, an O / V / W emulsion composition (Example 8) having vesicle-coated oily particles as a dispersed phase is an O / W emulsion composition (Comparative Example 7) in which the vesicle and the oil component are dispersed independently. ), It was found that an excellent effect of suppressing moisture transpiration was obtained.
また、実施例8のベシクル被覆水中油型乳化組成物を、半年間常温にて保管後、目視による外観変化、及び前記と同様に顕微鏡による組成物の構造確認を行ったが、O/V/W乳化組成物の分離、変色、変臭等もなく、ベシクル被覆油性粒子の構造変化もなく、安定に保持されていた。 Further, after the vesicle-coated oil-in-water emulsion composition of Example 8 was stored at room temperature for half a year, the appearance was visually changed and the structure of the composition was confirmed with a microscope in the same manner as described above. There was no separation, discoloration, odor and the like of the W emulsified composition, and there was no structural change of the vesicle-coated oily particles, and the emulsion was stably held.
Claims (4)
(A)大豆レシチン、卵黄レシチン、大豆レシチン水素添加物、卵黄レシチン水素添加物、ホスファチジルコリン、ホスファチジルエタノールアミン、ホスファチジルセリン、ホスファチジルグリセロール、ホスファチジルイノシトール及びスフィンゴリン脂質からなる群より選択される1種又は2種以上の両親媒性物質、
(B)イソノナン酸イソノニル、ジカプリン酸プロピレングリコール、イソステアリルアルコール、ジカプリル酸プロピレングリコール、トリオクタン酸トリメチロールプロパン、乳酸オクチルドデシル、ジイソステアリン酸ポリグリセリル、トリイソステアリン酸ポリグリセリル、イソステアリルグリセリルエーテル、下記一般式(1)で表されるプロピレングリコールモノエステル
からなる群より選択される1種又は2種以上の、IOB値が0.2〜0.54で、融点が30℃以下の油分、
(C)エチレングリコール、ジエチレングリコール、トリエチレングリコール、ポリエチレングリコール(平均分子量1000未満)、プロピレングリコール、ジプロピレングリコール、ポリプロピレングリコール(平均分子量:1000未満)、グリセリン、ジグリセリン、ポリグリセリン、イソプレングリコール、1,2−ペンタンジオール、1,3−ブチレングリコール及びヘキシレングリコールからなる群より選択される1種又は2種以上の多価アルコール、
(D)水性成分((C)多価アルコールは除く)、
(D)水性成分が連続相であり、成分(A)と成分(B)の一部とから形成された平均粒子径1〜5μmのベシクルにより、当該ベシクルに含まれない成分(B)の表面が被覆された、平均粒子径10〜60μmのベシクル被覆油性粒子が分散相であり、
(1)成分(A)、(B)及び(C)を相転移温度以上に加熱し、均一に混合させた後、
(2)相転移温度以上で成分(D)と混合し、その後、
(3)相転移温度以下に冷却する
ことにより得られる油/ベシクル/水型乳化組成物。 An oil / vesicle / water emulsion composition comprising the following components (A) to (D),
(A) One or two selected from the group consisting of soybean lecithin, egg yolk lecithin, soybean lecithin hydrogenated substance, egg yolk lecithin hydrogenated substance, phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylglycerol, phosphatidylinositol and sphingophospholipid More than a kind of amphiphile,
(B) isononyl isononanoate, propylene glycol dicaprate, isostearyl alcohol, propylene glycol dicaprylate, trimethylolpropane trioctanoate, octyldodecyl lactate, polyglyceryl diisostearate, polyglyceryl triisostearate, isostearyl glyceryl ether, the following general formula (1 ) Propylene glycol monoester represented by
One or more selected from the group consisting of: an IOB value of 0.2 to 0.54, and a melting point of 30 ° C. or less,
(C) ethylene glycol, diethylene glycol, triethylene glycol, polyethylene glycol (average molecular weight less than 1000), propylene glycol, dipropylene glycol, polypropylene glycol (average molecular weight: less than 1000), glycerin, diglycerin, polyglycerin, isoprene glycol, 1 , 2-pentanediol, 1,3-butylene glycol and hexylene glycol, one or more polyhydric alcohols selected from the group consisting of
(D) Aqueous component (excluding (C) polyhydric alcohol),
(D) The surface of the component (B) not contained in the vesicle by the vesicle having an average particle diameter of 1 to 5 μm formed from the component (A) and a part of the component (B), wherein the aqueous component is a continuous phase Vesicle-coated oily particles having an average particle diameter of 10 to 60 μm coated with
(1) After heating the components (A), (B) and (C) above the phase transition temperature and mixing them uniformly,
(2) mixing with component (D) above the phase transition temperature, then
(3) Cool below the phase transition temperature
An oil / vesicle / water emulsion composition obtained by
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015117262A JP6002816B2 (en) | 2015-06-10 | 2015-06-10 | Oil / vesicle / water emulsion composition and cosmetics containing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015117262A JP6002816B2 (en) | 2015-06-10 | 2015-06-10 | Oil / vesicle / water emulsion composition and cosmetics containing the same |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010114601A Division JP5794764B2 (en) | 2010-05-18 | 2010-05-18 | Method for producing oil / vesicle / water emulsion composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2015157868A JP2015157868A (en) | 2015-09-03 |
JP6002816B2 true JP6002816B2 (en) | 2016-10-05 |
Family
ID=54182118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015117262A Active JP6002816B2 (en) | 2015-06-10 | 2015-06-10 | Oil / vesicle / water emulsion composition and cosmetics containing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6002816B2 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61204109A (en) * | 1985-03-07 | 1986-09-10 | Eisai Co Ltd | Emulsion-type composition for external use |
JP4584543B2 (en) * | 2003-04-02 | 2010-11-24 | 株式会社資生堂 | Oil-in-water emulsion composition |
JP2004352689A (en) * | 2003-05-30 | 2004-12-16 | Kose Corp | O/w-type emulsion cosmetic |
JP3855203B2 (en) * | 2004-04-05 | 2006-12-06 | 学校法人神奈川大学 | Emulsifying dispersant, emulsifying dispersion method using the same, and emulsion |
JP2007077178A (en) * | 2005-09-09 | 2007-03-29 | Univ Kanagawa | Silicone type emulsion and its manufacturing method |
JP2011195510A (en) * | 2010-03-19 | 2011-10-06 | Shiseido Co Ltd | Oil-in-water type emulsified skin external composition |
-
2015
- 2015-06-10 JP JP2015117262A patent/JP6002816B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2015157868A (en) | 2015-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5758670B2 (en) | Oil-in-water emulsion composition | |
JP5128593B2 (en) | Skin external preparation in the form of water-in-oil emulsifier containing ceramide | |
WO2017104734A1 (en) | Oil-in-water type emulsion composition and method for producing same | |
JP6139206B2 (en) | Translucent or transparent composition | |
JP6377381B2 (en) | Liposome composition | |
JP5794764B2 (en) | Method for producing oil / vesicle / water emulsion composition | |
WO2013180157A1 (en) | Emulsion cosmetic composition | |
JP5623076B2 (en) | Vesicle composition and external preparation for skin | |
JP5491917B2 (en) | Emulsified cosmetics | |
JP2009102257A (en) | Liposome and skin cosmetic comprising the same | |
JP5710281B2 (en) | Solid lipid emulsion and topical skin preparation | |
JP5743479B2 (en) | Oil-in-water emulsion composition | |
JP4049216B2 (en) | Formulation with liquid crystal structure | |
JP6219029B2 (en) | O / W / O emulsifier type skin external preparation | |
JP2005179313A (en) | Method for producing base agent for skin cosmetic, and skin cosmetic | |
JP6861937B2 (en) | Liposomal composition with high transdermal absorbability and cosmetics or external preparations containing it | |
JP6606833B2 (en) | Ceramides-containing liposome dispersion | |
JP4799907B2 (en) | Emulsified cosmetic | |
JP6002816B2 (en) | Oil / vesicle / water emulsion composition and cosmetics containing the same | |
JP5555074B2 (en) | Solid lipid emulsion and topical skin preparation | |
JP5706223B2 (en) | W / O / W emulsion composition | |
WO2020230691A1 (en) | Composition containing ceramide and isobutyl oleate | |
JPH09132512A (en) | Lamellar structure of sterol fatty acid ester | |
JP6031182B1 (en) | Method for producing oil-in-water emulsion composition | |
JP7075955B2 (en) | Composition containing stearyl behendimonium ethyl phosphate, alkiloyl lactate and ceramides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150610 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150610 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160531 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160728 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160830 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160905 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 6002816 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |